Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Hematopoietic Cell Transplantation in the Treatment of Infant Leukemia and Myelodysplastic Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00357565
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:24.859769+00:00
Published At
2025-08-26T00:00:00+00:00
Record Updated At
2025-08-26
Results Posted At
2025-08-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Leukemia", "Myelodysplastic Syndromes", "Childhood Acute Myeloid Leukemia in Remission", "Recurrent Childhood Acute Myeloid Leukemia", "Secondary Acute Myeloid Leukemia", "Childhood Acute Lymphoblastic Leukemia in Remission", "Previously Treated Myelodysplastic Syndrome", "Secondary Myelodysplastic Syndrome", "Refractory Anemia With Excess Blasts in Transformation", "Refractory Anemia With Excess Blasts", "Refractory Anemia", "De Novo Myelodysplastic Syndrome", "Childhood Myelodysplastic Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-08-26"
protocolSection.identificationModule.nctId
"NCT00357565"
protocolSection.identificationModule.officialTitle
"Hematopoietic Cell Transplantation in the Treatment of Infant Leukemia and Myelodysplastic Syndrome"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-08-26"

Study condition terms

  • Leukemia (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myeloid Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Secondary Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Childhood Acute Lymphoblastic Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Previously Treated Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • Secondary Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • Refractory Anemia With Excess Blasts in Transformation (protocolSection.conditionsModule.conditions)
  • Refractory Anemia With Excess Blasts (protocolSection.conditionsModule.conditions)
  • Refractory Anemia (protocolSection.conditionsModule.conditions)
  • De Novo Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • Childhood Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.